Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
306.1500
9.85
(
3.32
%)
NSE
Mar 25, 2026
15:31 PM
75.51% Fall from 52W High
Volume:
644.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
16 Aug 2021
306.15
3.32%
Suven Pharmaceuticals
Buy:
Cohance Lifesciences Ltd.
by
ICICI Securities Limited
Target: 650
Target
ICICI Securities Limited
Cohance Lifesciences Ltd. is trading
below its 50 day SMA
of 337.1
More from Cohance Lifesciences Ltd.
Recommended
Between Swiggy and Zomato, Swiggy takes the dark patterns crown
The Baseline |
25 Mar 2026, 06:40PM
Market closes higher as the US seeks a month-long ceasefire in the Iran war
Trendlyne Marketwatch |
25 Mar 2026, 04:12PM
Five stocks to buy from analysts this week - March 24, 2026
The Baseline |
24 Mar 2026